Stockholders' Equity (Details Narrative) - USD ($)								1 Months Ended			3 Months Ended
	Dec. 26, 2019	Jun. 12, 2019	Apr. 23, 2019	Apr. 22, 2019	Jan. 29, 2019	Jan. 11, 2019	Dec. 26, 2018	Apr. 30, 2019	Mar. 31, 2019	Jan. 31, 2019	Jun. 30, 2019	Mar. 31, 2019	Mar. 31, 2018
Number of shares issued during the period, value												$ 83,000	$ 200,000
Common shares issued for settlement of accounts payable												$ 238,090
Common shares issued in conversion of warrants											$ 120
Autotelic Inc., [Member]
Shares issued price per share										$ 4.00
Common shares issued for settlement of accounts payable										$ 80,772
Employee [Member] | Oncotelic [Member]
Shares issued price per share						$ 4.00			$ 4.00			$ 4.00
Common shares issued for compensation						$ 11,250			$ 80,594
Two Separates Investors [Member] | Oncotelic [Member]
Number of shares issued during the period					20,750
Number of shares issued during the period, value					$ 83,000
Shares issued price per share					$ 4.00
Two Investors [Member]
Common shares issued in conversion of warrants								$ 150,000
Common shares issued in conversion of warrants, shares								120
Stock Purchase Agreement [Member] | Oncotelic [Member] | Autotelic Inc., [Member]
Number of shares issued during the period	226,988
Shares issued price per share	$ 4.00
Stock Purchase Agreement [Member] | Adhera Therapeutics [Member] | Convertible Series E Preferred Shares [Member] | Autotelic Inc., [Member]
Number of shares issued during the period	181.59
Number of shares issued during the period, value	$ 907,950
Stock Purchase Agreement [Member] | Autotelic Inc., [Member]
Number of shares issued during the period							226,988
Shares issued price per share							$ 4.00
Stock Purchase Agreement [Member] | Autotelic Inc., [Member] | Convertible Series E Preferred Shares [Member]
Number of shares issued during the period							181.59
Number of shares issued during the period, value							$ 907,950
Stock Purchase Agreement [Member] | Third-Party Investor [Member] | Oncotelic [Member]
Number of shares issued during the period	26,100
Stock Purchase Agreement [Member] | Third-Party Investor [Member] | Adhera Therapeutics [Member] | Convertible Series E Preferred Shares [Member]
Number of shares issued during the period	20.88
Number of shares issued during the period, value	$ 104,400
Stock Purchase Agreement [Member] | Vyoung Trieu [Member] | Oncotelic [Member]
Number of shares issued during the period	189,238
Shares issued price per share	$ 4.00
Stock Purchase Agreement [Member] | Vyoung Trieu [Member] | Adhera Therapeutics [Member] | Convertible Series E Preferred Shares [Member]
Number of shares issued during the period	151.39
Number of shares issued during the period, value	$ 756,950
Merger Agreement [Member]
Conversion of shares				10,318,746
Merger Agreement [Member] | Convertible Debt [Member]
Number of restricted stock issued during the period		350,000
Merger Agreement [Member] | Series A Convertible Preferred Stock [Member]
Conversion of shares				0.01877292
Merger Agreement [Member] | Oncotelic [Member]
Conversion of shares				41,000,033
Merger Agreement [Member] | Oncotelic [Member] | Series A Convertible Preferred Stock [Member]
Number of shares issued during the period				77,154
Conversion of shares			193,713	193,713
Merger Agreement [Member] | Two Noteholders [Member] | Convertible Debt [Member]
Shares issued price per share		$ 0.18	$ 0.11
Number of restricted stock issued during the period			700,000